Assistant Professor, Medicine, Vanderbilt University School of Medicine
Oncology
Dr. Vandana G. Abramson, MD
|
|
Give Review
Vandana Abramson practices Oncology. He graduated from University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. He received 1 awards: "Meaningful Use Stage 1 Certification". Doctor Vandana G. Abramson, MD has written publications. He has 30 publications published with PubMed. The lastest paper is: 'Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorse...' Vandana Abramson accepts Medicare payments and is listed with Medicare.gov.
Publications
- Predicting the Response of Breast Cancer to Neoadjuvant Therapy Using a Mechanically Coupled Reaction-Diffusion Model.
- Significance of Circulating Tumor Cells in metastatic triple negative breast cancer patients within a randomized, phase II trial: TBCRC 019.
- Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.
- Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging.
- TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.
- Subtyping of triple-negative breast cancer: Implications for therapy.
- Longitudinal, intermodality registration of quantitative breast PET and MRI data acquired before and during neoadjuvant chemotherapy: Preliminary results.
- Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next-Generation...
- An Approach to Breast Cancer Diagnosis via PET Imaging of Microcalcifications Using 18F-NaF.
- Stand up to cancer phase ib study of pan-phosphoinositide-3-kinase inhibitor buparlisib with letrozole in estrogen receptor-positive/human epidermal growth factor rece...
- Characterization of breast cancers with PI3K mutations in an academic practice setting using SNaPshot profiling.
- Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer.
- New strategies for triple-negative breast cancer--deciphering the heterogeneity.
- A mechanically coupled reaction-diffusion model for predicting the response of breast tumors to neoadjuvant chemotherapy.
- Thrombotic microangiopathy during docetaxel, trastuzumab, and carboplatin chemotherapy for early-stage HER2+ breast cancer: a case report.
- DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findings.
- Machine learning for predicting the response of breast cancer to neoadjuvant chemotherapy.
- Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
- Complications of targeted drug therapies for solid malignancies: manifestations and mechanisms.
- Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort.
- An algorithm for longitudinal registration of PET/CT images acquired during neoadjuvant chemotherapy in breast cancer: preliminary results.
- Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer.
- Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer.
- Clinical utility of serum tumor markers and circulating tumor cell assays in the treatment of breast cancer.
- Motion correction in diffusion-weighted MRI of the breast at 3T.
- Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome.
- New strategies in HER2-overexpressing breast cancer: many combinations of targeted drugs available.
- A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.
- Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorse...
Schools
University Of ChicagoThe Pritzker School Of Medicine
Bringham Womens Hospital
Univeristy Pennsylvania
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Network E
- Network S
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Coventry Health Care of Tennessee PPO
- GEHA
- Choice Care PPO
- Medicare MCR
- PHCS Network PPO
- POMCO Group
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- WellCare
Awards
- Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
Brigham and Women's Hospital -
University of Chicago Pritzker School of Medicine
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1154359602 | |
| NPPES Provider LastName | ABRAMSON | |
| NPPES Provider FirstName | VANDANA | |
| NPPES Provider ZIPCode | 372320021 | |
| NPPES Provider State | TN | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 509.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1154359602 |
| Last Name Of The Provider | ABRAMSON |
| First Name Of The Provider | VANDANA |
| View All |
Similar Doctors
|
Dr. Julie A. Means, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Karl M. Rogers, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jack W. Erter, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey A. Sosman, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anthony A. Meluch, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jordan D. Berlin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jerry M. Foster, MD |
|
|
Dr. Emily Chan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alicia K. Morgans, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl R. Willis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Spigel, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|